RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Healthwise Holdings Stock

China Healthwise Holdings Revenue 2024

China Healthwise Holdings Revenue

146.32 M HKD

Ticker

348.HK

ISIN

KYG2120E1290

In 2024, China Healthwise Holdings's sales reached 146.32 M HKD, a 3% difference from the 142.06 M HKD sales recorded in the previous year.

The China Healthwise Holdings Revenue history

YEARREVENUE (undefined HKD)GROSS MARGIN (%)
2023146.3241,21
2022142.0637,50
2021170.0853,50
2020137.8544,29
2019309.9728,25
2018451.6236,48
2017561.1928,81
2016319.226,94
2015352.817,80
2014389.4328,74
2013193.730,77
2012209.325,51
2011419.815,58
201053816,51
2009402.419,83
2008637.218,77
2007799.124,44
2006704.829,54
2005750.628,74
2004774.726,86

China Healthwise Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into China Healthwise Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Healthwise Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Healthwise Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of China Healthwise Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into China Healthwise Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing China Healthwise Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Healthwise Holdings’s growth potential.

China Healthwise Holdings Revenue, EBIT and net profit per share

DateChina Healthwise Holdings RevenueChina Healthwise Holdings EBITChina Healthwise Holdings Net Income
2023146.32 M HKD-4.93 M HKD-134.56 M HKD
2022142.06 M HKD-12.74 M HKD-54.27 M HKD
2021170.08 M HKD26.98 M HKD-103.05 M HKD
2020137.85 M HKD4.29 M HKD-25.22 M HKD
2019309.97 M HKD-23.62 M HKD-124.35 M HKD
2018451.62 M HKD-10.44 M HKD-95.32 M HKD
2017561.19 M HKD-44.36 M HKD-186.1 M HKD
2016319.22 M HKD-167.91 M HKD-241.94 M HKD
2015352.8 M HKD-82.36 M HKD-81.32 M HKD
2014389.43 M HKD-19.14 M HKD17.04 M HKD
2013193.7 M HKD-13.9 M HKD5.3 M HKD
2012209.3 M HKD2.4 M HKD2.2 M HKD
2011419.8 M HKD4.1 M HKD77.6 M HKD
2010538 M HKD-107.7 M HKD-197.5 M HKD
2009402.4 M HKD-145.9 M HKD-175 M HKD
2008637.2 M HKD-135.4 M HKD-288.8 M HKD
2007799.1 M HKD4.1 M HKD4.4 M HKD
2006704.8 M HKD-9.4 M HKD-37.2 M HKD
2005750.6 M HKD38.9 M HKD16.7 M HKD
2004774.7 M HKD35.9 M HKD20.3 M HKD

China Healthwise Holdings stock margins

The China Healthwise Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Healthwise Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Healthwise Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the China Healthwise Holdings's sales revenue. A higher gross margin percentage indicates that the China Healthwise Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the China Healthwise Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the China Healthwise Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Healthwise Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Healthwise Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Healthwise Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

China Healthwise Holdings Margin History

China Healthwise Holdings Gross marginChina Healthwise Holdings Profit marginChina Healthwise Holdings EBIT marginChina Healthwise Holdings Profit margin
202341.21 %-3.37 %-91.96 %
202237.5 %-8.97 %-38.21 %
202153.5 %15.86 %-60.59 %
202044.29 %3.11 %-18.3 %
201928.25 %-7.62 %-40.12 %
201836.48 %-2.31 %-21.11 %
201728.81 %-7.9 %-33.16 %
20166.94 %-52.6 %-75.79 %
201517.8 %-23.35 %-23.05 %
201428.74 %-4.92 %4.37 %
201330.77 %-7.18 %2.74 %
201225.51 %1.15 %1.05 %
201115.58 %0.98 %18.48 %
201016.51 %-20.02 %-36.71 %
200919.83 %-36.26 %-43.49 %
200818.77 %-21.25 %-45.32 %
200724.44 %0.51 %0.55 %
200629.54 %-1.33 %-5.28 %
200528.74 %5.18 %2.22 %
200426.86 %4.63 %2.62 %

China Healthwise Holdings Aktienanalyse

What does China Healthwise Holdings do?

China Healthwise Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding China Healthwise Holdings's Sales Figures

The sales figures of China Healthwise Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing China Healthwise Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize China Healthwise Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in China Healthwise Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about China Healthwise Holdings stock

How much revenue did China Healthwise Holdings generate this year?

China Healthwise Holdings has achieved a revenue of 146.32 M HKD this year.

How much was the turnover of the company China Healthwise Holdings compared to the previous year?

The revenue of China Healthwise Holdings has increased by 3% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of China Healthwise Holdings?

The revenue of China Healthwise Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of China Healthwise Holdings measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of China Healthwise Holdings so important for investors?

The revenue of China Healthwise Holdings is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does China Healthwise Holdings pay?

Over the past 12 months, China Healthwise Holdings paid a dividend of 0.02 HKD . This corresponds to a dividend yield of about 33.4 %. For the coming 12 months, China Healthwise Holdings is expected to pay a dividend of 0 HKD.

What is the dividend yield of China Healthwise Holdings?

The current dividend yield of China Healthwise Holdings is 33.4 %.

When does China Healthwise Holdings pay dividends?

China Healthwise Holdings pays a quarterly dividend. This is distributed in the months of January, September, January, October.

How secure is the dividend of China Healthwise Holdings?

China Healthwise Holdings paid dividends every year for the past 0 years.

What is the dividend of China Healthwise Holdings?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is China Healthwise Holdings located?

China Healthwise Holdings is assigned to the 'Cyclical consumption' sector.

Wann musste ich die Aktien von China Healthwise Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Healthwise Holdings from 9/22/2005 amounting to 0.005 HKD, you needed to have the stock in your portfolio before the ex-date on 9/1/2005.

When did China Healthwise Holdings pay the last dividend?

The last dividend was paid out on 9/22/2005.

What was the dividend of China Healthwise Holdings in the year 2023?

In the year 2023, China Healthwise Holdings distributed 0 HKD as dividends.

In which currency does China Healthwise Holdings pay out the dividend?

The dividends of China Healthwise Holdings are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Healthwise Holdings

Our stock analysis for China Healthwise Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Healthwise Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.